In the context of triple-negative breast cancer (TNBC), where dysregulated protein translation drives tumor progression and metastasis, high rate of relapse, and resistance to radio- and chemotherapy, an understanding of the unique contributions of eukaryotic initiation factor 4 A (eIF4A) paralogs is important. This evidence concerns the gene EIF4A2 and triple-negative breast carcinoma.